Mucinex Sinus-max Capsule, Liquid Filled
NDC Package 63824-693-08
Package Information
Mucinex Sinus-max (acetaminophen, dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride) capsules is do not take more than directed (see Overdose warning)do not take more than 12 liquid gels in any 24-hour periodadults and children 12 years of age and older: take 2 liquid gels every 4 hourschildren under 12 years of age: do not use. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Reckitt Benckiser Llc, this product is identified by NDC 63824-693 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1656815 - acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Capsule
- RxCUI: 1656815 - acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Capsule
- RxCUI: 1656815 - APAP 325 MG / Dextromethorphan Hydrobromide 10 MG / Guaifenesin 200 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 63824 - Reckitt Benckiser Llc
- 63824-693 - Mucinex Sinus-max
- 63824-693-08 - 1 BLISTER PACK in 1 CARTON / 8 CAPSULE, LIQUID FILLED in 1 BLISTER PACK
- 63824-693 - Mucinex Sinus-max
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (63824-693). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63824-693-08 identifies a specific commercial package of 1 blister pack in 1 carton / 8 capsule, liquid filled in 1 blister pack of Mucinex Sinus-max Pressure, Pain And Cough, a human over the counter drug labeled by Reckitt Benckiser Llc. This capsule, liquid filled is formulated for oral use and contains acetaminophen; dextromethorphan hydrobromide; guaifenesin; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Reckitt Benckiser Llc on July 01, 2017. The current certification is valid through December 31, 2027.
How is this Reckitt Benckiser Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63824069308. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.